BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 6, 2018
View Archived Issues
Immix studies IMX-110 in patients with advanced solid tumors
Read More
Global BioLife completes Zaire Ebola research portion for study of LB-2
Read More
CXCR2 targeting suppresses allergic airway inflammation in mice
Read More
Magenta and Heidelberg Pharma sign exclusive multi-target research agreement
Read More
Zynerba plans pivotal study with ZYN-002 in fragile X syndrome
Read More
Vividion and Celgene enter strategic research collaboration
Read More
G1 Therapeutics reports phase IIa data on trilaciclib in extensive-stage SCLC
Read More
Promising topline data from pivotal phase III study of CLS-TA in uveitic macular edema
Read More
AEC syndrome pathology linked to protein aggregation of the p63 transcription factor
Read More
Phase III trials of olumacostat glasaretil for acne do not meet co-primary endpoints
Read More
FDA grants rare pediatric disease designation to Prometic's inter-alpha inhibitor proteins
Read More
Aminoacyclase-1 is a novel potential biomarker for schizophrenia
Read More
Enrollment begins in phase I study of treprostinil Technosphere
Read More
Safety, eosinophil reductions encourage further development of AK-002
Read More
Sorrento reports initial data from phase Ib study of autologous anti-CEA CAR T cells
Read More
Enteris signs feasibility development agreement with Ferring
Read More
Chi-Med initiates proof-of-concept study of epitinib in glioblastoma
Read More
Sanifit completes phase II trial of SNF-472 for calciphylaxis in patients on dialysis
Read More
Researchers mimic human walnut allergy in mice
Read More
Nightstar Therapeutics initiates phase III STAR trial of NSR-REP1 for choroideremia
Read More
Novel tubulin polymerization inhibitors discovered at Athenex
Read More
Merck & Co. patents new HCV NS5B inhibitors
Read More
Orbis Health Solutions presents anti-CTLA4 and PD-1-encoding bead vectors
Read More
Immatics Biotechnologies divulges novel constructs binding COL6A3 antigens
Read More